Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Exclusive rights to NX-211 obtained by Gilead from GSK

Jan. 17, 2001

IntraBiotics completes patient enrollment in phase III Protegrin IB-367 Rinse study

Jan. 17, 2001

Update on Active Biotech's TTS products under clinical development

Jan. 17, 2001

Telik and the University of Arizona enter TRAP alliance

Jan. 17, 2001

Genome-derived candidate for oncology identified as part of Millennium/Bayer alliance

Jan. 17, 2001

Xcytrin clinical development program update

Jan. 16, 2001

New antitumor prodrugs activated by FAPalpha

Jan. 15, 2001

Inhibitors of growth factor receptor tyrosine kinases developed at BMS

Jan. 15, 2001

Sonus begins phase I evaluation of less toxic form of paclitaxel

Jan. 15, 2001

Sanofi-Synthelabo to market Leuprogel in the U.S. and Canada

Jan. 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...